Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)

NCT03887884 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: CVT-301
DRUG: Sinemet

Sponsor

Acorda Therapeutics